»çÀÌÆ®¸Ê
ÀÌ¿ë¾È³»
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀ̼Ç
Ȩ
Ä«Å×°í¸®
¸ÂÃãÇü½ÃÀåÁ¶»ç
±¹Á¦ÄÁÆÛ·±½º
±Û·Î¹ú ÆÄÆ®³Ê
¸ÞÀϸµ ¼ºñ½º
ȸ»ç¼Ò°³
°æ¿µÀ̳ä
»ç¾÷¿µ¿ª
ÁöÁ¡¾È³»
°í°´»ç ¸ñ·Ï
±Û·Î¹ú ÆÄÆ®³Ê
ÀÌ¿ë¾à°ü
Contact Us
Ȩ
>
±Û·Î¹ú ÆÄÆ®³Ê
>
P
> PharmaVentures Ltd
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
Y
Z
PharmaVentures Ltd
PharmaVentures Ltd ¿¡¼ ¹ßÇàÇÑ ÀÚ·á ¸®½ºÆ®ÀÔ´Ï´Ù.
Á¦¸ñ °Ë»ö
1
-
8
¸®ºä (Àüü£º
8
°Ç)
Á¤·Ä
¹ßÇàÀÏ
ÇѱÛÁ¦¸ñ
¿µ¹®Á¦¸ñ
¸®¼Ä¡»ç
°¡°Ý
Ç¥½Ã °Ç¼ö
25
50
100
·Î¿Æ¼À² ¸®Æ÷Æ®(2012³â) : ÀǾàǰ ºÎ¹®ÀÇ Á¾ÇÕÀû °¡Ä¡ Æò°¡
The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
»óǰÄÚµå :230265
Á¦¾à ¾÷°èÀÇ ·Î¿Æ¼À²(Royalty Rate)¿¡ ´ëÇØ ºÐ¼®Çϰí, °¢Á¾ °è¾à ¹× ·Î¿Æ¼ ±¸Á¶, À¯È¿ÇÑ ·Î¿Æ¼ ºñ±³ ºÐ¼®, ·Î¿Æ¼ »êÃâ, ¼øÇöÀç°¡Ä¡(NPV)¿Í ±â´ë ¼øÇöÀç°¡Ä¡(ENPV) »êÃâ, ´Ü°è ¹× ÀûÀÀÁõº° ·Î¿Æ¼À², °ú°Å 5³â°£ ·Î¿Æ¼À² º¯È µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý
US $ 8,005
¹ßÇàÀÏ
2012³â 03¿ù
¸®¼Ä¡»ç
PharmaVentures Ltd
ÆäÀÌÁö¼ö
Áß¿ä °Å·¡ µ¿Çâ : ¾Ï(2011³â)
Essential Deal Trends: Oncology 2011
»óǰÄÚµå :221315
¾Ï(Oncology) ½ÃÀåÀÇ ÇÕº´, Àμö, ¶óÀ̼¾½Ì µîÀÇ Áß¿ä °Å·¡ µ¿ÇâÀ» Á¤¸®Çϰí, 2000³â ÀÌÈÄÀÇ ½ÇÀû°ú ÇâÈÄ ¿¹ÃøÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý
US $ 2,395
¹ßÇàȽ¼ö
12 ȸ / ³â
¸®¼Ä¡»ç
PharmaVentures Ltd
ÆäÀÌÁö¼ö
60 Pages
¹é½Å ºÐ¾ßÀÇ °Å·¡ ºÐ¼®
Analysis of Deal Making in Vaccines
»óǰÄÚµå :138235
¹é½Å ½ÃÀåÀÇ °Å·¡ µ¿Çâ¿¡ ´ëÇØ ºÐ¼®ÇßÀ¸¸ç, Ä¡·á ºÐ¾ßº°, Á¾·ùº°, °³¹ß ´Ü°èº°, Á¦Ç°º° µîÀÇ ºÎ¹®º° µ¿Çâ°ú Âü¿©±â¾÷ÀÇ °³¿ä, ÄÉÀ̽º½ºÅ͵𸦠Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý
US $ 3,344
¹ßÇàÀÏ
2010³â 11¿ù
¸®¼Ä¡»ç
PharmaVentures Ltd
ÆäÀÌÁö¼ö
½Å°æ º¯¼º ÁúȯÀÇ °Å·¡ ºÐ¼®
Analysis of Deals in Neurodegenerative Diseases
»óǰÄÚµå :127549
½Å°æ º¯¼º Áúȯ(¾ËÃ÷ÇÏÀ̸Ӻ´, ÆÄŲ½¼º´, ´Ù¹ß¼º °æÈÁõ, °£Áú, ÆíµÎÅë µî)ÀÇ °³¿ä¿Í ½ÃÀå ±Ô¸ð, ÇöÀç Ä¡·á¹ý°ú °³¹ß ÁßÀÎ Á¦Ç° µ¿Çâ, Á¾·ù¡¤°³¹ß ´Ü°è¡¤Á¦Ç°º° °Å·¡ µ¿Çâ µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý
US $ 3,344
¹ßÇàÀÏ
2010³â 07¿ù
¸®¼Ä¡»ç
PharmaVentures Ltd
ÆäÀÌÁö¼ö
¾Ï ºÐ¾ß¿¡¼ÀÇ ±â¾÷ °Å·¡ : °Å·¡ ±¸Á¶¿Í °¡Ä¡ Æò°¡
Analysis of Oncology Deals: Trends in Deal Structures and Valuations
»óǰÄÚµå :104712
¾Ï ½ÃÀå Âü°¡ ±â¾÷ÀÇ °³¿ä¿Í ÁÖ¸ñÇØ¾ß ÇÒ Áß¼Ò±â¾÷, ±ÝÀ¶À§±â°¡ µ¿ ½ÃÀå¿¡¼ÀÇ ±â¾÷ °Å·¡¿¡ ¹ÌÄ£ ¿µÇâ, ½ÅÈï ½ÃÀåÀÇ µ¿Çâ, ÇâÈÄÀÇ °Å·¡¸¦ ÃËÁøÇϱâ À§ÇÑ »õ·Î¿î Å×Å©³î·¯Áö¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý
US $ 2,395
¹ßÇàÀÏ
2009³â 12¿ù
¸®¼Ä¡»ç
PharmaVentures Ltd
ÆäÀÌÁö¼ö
100 PAGES
ÀǾàǰÀÇ °¢Á¾ °è¾à µ¿Çâ
Trends in Pharmaceutical Deal Making, An analysis of valuations, deal structures and deal types
»óǰÄÚµå :89954
Á¦¾à±â¾÷ÀÇ °è¾à µ¿Çâ¿¡ ´ëÇØ °è¾à À¯Çüº°·Î Á¶»ç ºÐ¼®Çϰí, °¢Á¾ °è¾àÀÇ ÇÕ¸®¼º, °¢Á¾ °è¾àÀÇ Æò°¡ ¹æ¹ý, °¢Á¾ °è¾àÀÇ ±Ô¸ð(Áö¿ª¡¤ÀÓ»ó ºÐ¾ßº°), ÁÖ¿ä±â¾÷ »ç·Ê¿¬±¸ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý
US $ 2,450
¹ßÇàÀÏ
2009³â 06¿ù
¸®¼Ä¡»ç
PharmaVentures Ltd
ÆäÀÌÁö¼ö
97 Pages
ÀǾàǰ ¾÷°èÀÇ ¶óÀ̼¾½Ì °è¾à Æò°¡ °¡À̵å
Guide to Valuation of Pharmaceutical Licensing Deals
»óǰÄÚµå :89963
´ë±Ô¸ð Á¦¾à ȸ»ç ¹× ¹ÙÀÌ¿À ±â¾÷, Çмú ±â°ü°úÀÇ ³×Æ®¿öÅ© ¾È¿¡¼ ÇàÇØÁö´Â ¶óÀ̼¾½º °è¾àÀÇ ´Ù¾çÇÑ ¹®Á¦Á¡¿¡ ÃÊÁ¡À» ¸ÂÃß¾î Á¤È®ÇÑ °¡Ä¡ Æò°¡ ¹× °¡Ä¡ âÃâ ÇÁ·Î¼¼½º, ÇâÈÄÀÇ ¼Õ½Ç ÃÖ¼Òȸ¦ À§ÇÑ Àü·« µîÀ» Á¤¸®ÇØ µå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý
US $ 2,450
¹ßÇàÀÏ
2009³â 03¿ù
¸®¼Ä¡»ç
PharmaVentures Ltd
ÆäÀÌÁö¼ö
98 Pages
¾à¹° Àü´Þ(Drug Delivery) ºÐ¾ßÀÇ È¿°úÀû °Å·¡
Effective Deal Making in Drug Delivery
»óǰÄÚµå :89955
ÀǾàǰ ¾÷°èÀÇ ¾à¹° Àü´Þ(Drug Delivery)À» À§ÇÑ Àü·«°ú Ÿ»ç¿ÍÀÇ Á¦ÈÞ °è¾à, ´ë±Ô¸ð Á¦¾à ȸ»çÀÇ Á¦ÈÞ »ç·Ê ¹× Á¦ÈÞ °³¹ß ÇÁ·Î¼¼½º µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý
US $ 5,993
¹ßÇàÀÏ
2009³â 01¿ù
¸®¼Ä¡»ç
PharmaVentures Ltd
ÆäÀÌÁö¼ö
142 Pages
»ó±â ÀÚ·á ÀÌ¿ÜÀÇ
PharmaVentures Ltd
ÀÚ·áµµ ÁÖ¹® °¡´ÉÇÏ´Ï
¹®ÀÇ
ÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.